Table 1Base case results for the Incremental cost-effectiveness of the four strategies for cascade testing

StrategyCost (£)Effect (QALYs)Incremental cost (£)Incremental effect (QALY)ICER (£/QALY)
Cholesterol£38,92132.87
DNA£44,81630.63---
DNA + Chol M-ve DF£46,47931.91---
DNA + Chol M-ve DF +PFH£51,92437.73£13,0034.86£2,676

From: 4, Identification strategies

Cover of Identification and Management of Familial Hypercholesterolaemia (FH)
Identification and Management of Familial Hypercholesterolaemia (FH) [Internet].
NICE Clinical Guidelines, No. 71.
National Collaborating Centre for Primary Care (UK).
Copyright © 2008, Royal College of General Practitioners.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.